All Publications

Phase 2 multicenter trial of ofatumumab and prednisone as initial therapy of chronic graft-vs-host disease

1-11-2022

Article

Additional authors and institutional affiliations

Blood Adv (2022) 6(1): 259-269

This document is currently not available here.

COinS